Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2024-11-07 00:00:00 ET · period of report 2024-11-05 · accession 0001415889-24-026386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-07 | 2024-11-05 | JANX | Gujrathi Sheila | Dir | J - Other | $0.00 | +4,611 | 115.1K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-05 | J | A | 4,611 | $0.00 | 115,139 | D | — | — |